Mitigating FCPA Risks in Pharma, Med Device Sectors

Image: SEC Enforcement Director Andrew Ceresney recently dropped new hints on FCPA risks for pharma and medical devices, plus suggestions on how to avoid those risks. “Our FCPA focus obviously covers many industries,” he said. “But the pharma industry is one on which we have been particularly focused in recent ...

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.